Sensei Biotherapeutics (NASDAQ:SNSE – Get Free Report) will likely be releasing its earnings data before the market opens on Wednesday, February 26th. Analysts expect Sensei Biotherapeutics to post earnings of ($0.27) per share for the quarter.
Sensei Biotherapeutics Trading Down 5.1 %
Shares of SNSE stock opened at $0.45 on Monday. The stock has a market capitalization of $11.33 million, a price-to-earnings ratio of -0.38 and a beta of 0.17. The stock has a fifty day simple moving average of $0.49 and a two-hundred day simple moving average of $0.52. Sensei Biotherapeutics has a twelve month low of $0.38 and a twelve month high of $1.94.
Analyst Upgrades and Downgrades
Separately, HC Wainwright restated a “buy” rating and set a $4.00 price objective on shares of Sensei Biotherapeutics in a research note on Wednesday, January 8th.
Sensei Biotherapeutics Company Profile
Sensei Biotherapeutics, Inc, an immuno-oncology company, engages in the discovery and development of therapeutics for cancer patients. The company's Tumor Microenvironment Activated Biologics platform is designed to generate highly selective therapeutics that disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment.
Featured Stories
- Five stocks we like better than Sensei Biotherapeutics
- How to Use the MarketBeat Dividend Calculator
- Why Genuine Parts Company Is a Royally Good Buy Right Now
- Airline Stocks – Top Airline Stocks to Buy Now
- Industrials Are Quietly Outpacing the Market: 3 Stocks to Watch
- Which Wall Street Analysts are the Most Accurate?
- These 5 Energy Stocks Hedge Inflation With Growth Potential
Receive News & Ratings for Sensei Biotherapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sensei Biotherapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
